GLENN A EISENBERG, the Executive Vice President of $LH ($LH), sold 11,711 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 27.2%...
Dwight Gary Gilliland, a director at $LH ($LH), sold 1,000 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 11.5% of their shares....
Amy B. Summy, the EVP of $LH ($LH), sold 3,671 shares of the company on 11-22-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 46.0% of their shares. Following...
/Labcorp%20Holdings%20Inc_%20location-by%20Sundry%20Photography%20via%20iStock.jpg)
Despite Labcorp Holdings’ underperformance relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.
der Vaart Sandra D van, the EVP of $LH ($LH), sold 1,000 shares of the company on 11-21-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 27.3% of their shares....
/Labcorp%20Holdings%20Inc_%20logo%20magnified-by%20ll_studio%20via%20Shutterstock.jpg)
With Labcorp Holdings gearing up to release its third-quarter earnings later this month, analysts expect single-digit earnings growth.
Labcorp Holdings recently outperformed the healthcare sector peers, and Wall Street analysts are moderately optimistic about the stock’s prospects.
Labcorp Holdings has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.